Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder

Neuropsychopharmacology

Volumn 32, Issue 10, 2007, Pages 2190-2198

  Epperson, Cynthia Neill ^a,b   Pittman, Brian ^a,b   Czarkowski, Kathryn Ann ^a,b   Stiklus, Stephanie ^a,b   Krystal, John Harrison ^a,b   Grillon, Christian ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale University School of Medicine   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Affect; Arousal; Menstrual cycle; PMDD; Startle; Valence

Indexed keywords

ADULT; AFFECT; ARTICLE; AUDITORY STIMULATION; AVERSIVE BEHAVIOR; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLICULAR PHASE; HUMAN; LUTEAL PHASE; MENSTRUAL CYCLE; PHYSIOLOGY; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; STARTLE REFLEX; STIMULUS RESPONSE;

ACOUSTIC STIMULATION; ADULT; ANXIETY; AROUSAL; BRAIN CHEMISTRY; FEMALE; GONADAL STEROID HORMONES; HUMANS; LUTEAL PHASE; MOOD DISORDERS; NEUROPSYCHOLOGICAL TESTS; PHOTIC STIMULATION; PREMENSTRUAL SYNDROME; STARTLE REACTION;

EID: 34548597535     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301351     Document Type: Article

References (62)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Press: Washington, DC.
2. Auger CJ, Vanzot RJ (2006). Progesterone treatment of adult male rats suppresses arginine vasopressin expression in the bed nucleus of the stria terminalis and the centromedial amygdala. J Neuroendocrinol 18: 187-194.
3. Barbaccia ML, Roscetti G, Trabucchi M, Purdy RH, Mostallino MC, Concas A et al (1997). The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations. Br J Pharmacol 120: 1582-1588.
4. Barbaccia ML, Serra M, Purdy RH, Biggio G (2001). Stress and neuroactive steroids. Int Rev Neurobiol 46: 243-272.
5. Bernardi F, Pluchino N, Begliuomini S, Lenzi E, Palumbo M, Luisi M et al (2004). Disadaptive disorders in women: allopregnanolone, a sensitive steroid. Gynecol Endocrinol 19: 344-353.
6. Bradley MM, Cuthbert BN, Lang PJ (1993). Pictures as prepulse: attention and emotion in startle modification. Psychophysiology 30: 541-545.
7. Bradley MM, Lang PJ (1994). Measuring emotion: the self-assessment manikin and the semantic differential. J Behav Ther Exp Psychiatry 25: 49-59.
8. Cook EW, Hawk LW, Davis TL, Stevenson VE (1991). Affective individual differences and startle reflex modulation. J Abnormal Psychol 100: 5-13.
9. Davis M, Gilmore RL (1998). Anatomic and physiologic substrates of emotion in an animal model. J Clin Neurophysiol 15: 378-387.
10. Davis M, Shi C (1999). The extended amygdala: are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety? Ann NY Acad Sci 877: 281-291.
11. Davis M, Walker D, Lee Y (1997). Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex. Philos Trans R Soc London B Biol Sci 352: 1675-1687.
12. Dichter GS, Tomarken AJ, Shelton RC, Sutton SK (2004). Earlyand late-onset startle modulation in unipolar depression. Psychophysiology 41: 433-440.
13. Droogleever Fortuyn HA, van Broekhoven F, Span PN, Backstrom T, Zitman FG, Verkes RJ (2004). Effects of PhD examination stress on allogrenanolone and cortisol plasma levels and peripheral benzodiazepine receptor density. Psychoneuroendocrinology 29: 1341-1344.
14. A inhibition of bed nucleus of the stria terminalis neurons projecting to the ventral tegmental area. J Neurosci 24: 8198-8204.
15. Endicott J, Harrison W (1990). Daily Rating of Severity of Problems Form. Department of Research Assessment and Training, New York State Psychiatric Institute: New York, NY.
16. Endicott J, Nee J, Harrison W (2006). Daily record of severity of problems (DRSP): reliability and validity. Arch Women's Mental Health 9: 41-49.
17. Epperson CN, Haga KK, Mason GF, Sellers E, Gueorguieva R, Zhang W et al (2002). Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 59: 851-858.
18. Epperson CN, Wisner KL, Yamamoto B (1999). Gonadal steroids in the treatment of mood disorders. Psychosom Med 61: 676-697.
19. Eriksson O, Backstrom T, Stridsberg M, Hammarlund-Udenaes M, Naessen T (2006). Differential response to estrogen challenge test in women with and without premenstrual dysphoria. Psychoneuroendocrinology 31: 415-427.
20. First MB, Spitzer RL, Gibbon M, Williams JBW (1998). Structured Clinical Interview for DSM-IV Axis I Disorders. Biometrics Research Department, New York State Psychiatric Institute: New York, NY.
21. Fonseca E, Basurto L, Velazquez S, Zarate A (2001). Hormone replacement therapy increases ACTH/dehydroepiandrosterone sulfate in menopause. Maturitas 39: 57-62.
22. Gallant SJ, Popiel DA, Hoffman DM, Chakraborty PK, Hamilton JA (1992). Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part I. Effects of demand characteristics and expectations. Psychosom Med 54: 149-166.
23. Genazzani AR, Petraglia F, Bernadi F, Casarosa E, Salvestroni C, Tonetti A et al (1998). Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J Clin Endocrinol Metab 83: 2099-2103.
24. Girdler SS, Straneva PA, Light KC, Pederson CA, Morrow AL (2001). Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry 49: 788-797.
25. Grillon C, Baas J (2003). A review of the modulation of the startle reflex by affective states and its application in psychiatry. Clin Neurophysiol 114: 1557-1579.
26. Grillon C, Morgan CA, Davis M, Southwick SM (1998a). Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder. Biol Psychiatry 44: 1027-1036.
27. Grillon C, Morgan CA, Southwick SM, Davis M, Charney DS (1996). Baseline startle amplitude and prepulse inhibition in Vietnam veterans with PTSD. Psychiatry Res 64: 169-178.
28. Gulinello M, Gong QH, Smith SS (2002). Progesterone withdrawal increases the alpha4 subunit of the GABA(A) receptor in male rats in association with anxiety and altered pharmacology - a comparison with female rats. Neuropharmacology 43: 701-714.
29. Gulinello M, Orman R, Smith SS (2003). Sex differences in anxiety, sensorimotor gating and expression of the alpha4 subunit of the GABAA receptor in the amygdala after progesterone withdrawal. Eur J Neurosci 17: 641-648.
30. Gulinello M, Smith SS (2003). Anxiogenic effects of neurosteroid exposure: sex differences and altered GABAA receptor pharmacology in adult rats. J Pharmacol Exp Ther 305: 541-548.
31. B transmissions in lateral amygdala are involved in startle-like electromyographic (EMG) potentiation caused by activation of auditory thalamus. Neurosci Lett 374: 113-118.
32. Herman JP, Mueller NK, Figueiredo H (2004). Role of GABA and glutamate circuitry in hypothalamo-pituitary-adrenocorticol stress integration. Ann NY Acad Sci 1018: 35-45.
33. Hochberg Y, Tamhane AC (1987). Multiple Comparisons Procedures. John Wiley & Sons: New York, NY.
34. Isgor C, Huang GC, Akil H, Watson SJ (2002). Correlation of estrogen ß-receptor messenger RNA with endogenous levels of plasma estradiol and progesterone in the female rat hypothalamus, the bed nucleus of stria terminalis and the medial amygdala. Mol Brain Res 106: 30-41.
35. Jovanovic T, Szilagyi S, Chakravorty S, Fiallos AM, Lewison BJ, Parwani A et al (2004). Menstrual cycle phase effects on prepulse inhibition of acoustic startle. Psychophysiology 41: 401-406.
36. Koch M (1999). The neurobiology of startle. Prog Neurobiol 59: 107-128.
37. Lang PJ, Bradley MM, Cuthbert BN (1990). Emotion, attention, and the startle reflex. Psychol Rev 97: 377-395.
38. Lang PJ, Bradley MM, Cuthbert BN (1998). E motion, motivation, and anxiety: brain mechanisms and psychophysiology. Biol Psychiatry 44: 1248-1263.
39. Lang PJ, Bradley MM, Cuthbert BN (2005). International affective picture system (IAPS): digitized photographs, instruction manual and affective ratings. Technical Report A-6. University of Florida: Gainesville, FL.
40. Lewis LL (1995). One year in the life of a woman with premenstrual syndrome: a case study. Nurs Res 44: 111-116.
41. Lombardi I, Luisi S, Quirici P, Monteleone F, Bernardi F, Liut M et al (2004). Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome. Gynecol Endocrinol 18: 79-87.
42. Monteleone P, Luisi S, Tonetti A, Bernardi F, Genazzani AD, Luisi M et al (2000). Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol 142: 269-273.
43. Morgan III CA, Grillon C, Southwick SM, Davis M, Charney DS (1995). Fear-potentiated startle in posttraumatic stress disorder. Biol Psychiatry 38: 378-385.
44. Morris JS, Ohman A, Dolan RJ (1998). Conscious and unconscious emotional learning in the human amygdala. Nature 393: 467-470.
45. N-Wihlback AC, Sundstrom-Poromaa I, Backstrom T (2006). Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders. Psychopharmacology 186: 388-401.
46. Orr SP, Solomon Z, Peri T, Pitman RK, Shalev AY (1997). Physiologic responses to loud tones in Israeli veterans of the 1973 Yom Kippur War. Biol Psychiatry 41: 319-326.
47. Patchev VK, Shoaib M, Holsboer F, Almeida OFX (1994). The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience 62: 265-271.
48. Schmid A, Koch M, Schnitzler HU (1995). Conditioned pleasure attenuates the startle response in rats. Neurobiol Learning Memory 64: 1-3.
49. Schmidt PJ, Grover GN, Hoban MC, Rubinow DR (1990). State-dependent alterations in the perception of life events in menstrual-related mood disorders. Am J Psychiatry 147: 230-234.
50. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR (1998). Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. New Engl J Med 338: 209-216.
51. Smith MJ, Adams LF, Schmidt PJ, Rubinow DR, Wassermann EM (2003). Abnormal luteal phase excitability of the motor cortex in women with premenstrual syndrome. Biol Psychiatry 54: 757-762.
52. Spielberger CD (1984). State-Trait Anxiety Inventory: A Comprehensive Bibliography. Consultant Psychologists Press: Palo Alto, CA.
53. Spitzer RL, Williams JBW, Gibbon M, First MB (1990). Structured Clinical Interview for DSM-III-R-Non-Patient Edition (SCID-NP, Version 1.0). American Psychiatric Press: Washington, DC.
54. Sundstrom I, Andersson A, Nyberg S, Ashbrook D, Purdy RH, Backstrom T (1998). Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 67: 126-138.
55. Sundstrom I, Backstrom T, Wang M, Olsson T, Seippel L, Bixo M (1999). Premenstrual syndrome, neuroactive steroids and the brain. Gynecol Endocrinol 13: 206-220.
56. Sundstrom-Poromaa I, Smith S, Gulinello M (2003). GABA receptors, progesterone and premenstrual dysphoric disorder. Arch Women's Mental Health 6: 23-41.
57. Swerdlow NR, Hartman PL, Auerbach PP (1997). Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders. Biol Psychiatry 41: 452-460.
58. Toufexis DJ, Davis C, Hammond A, Davis M (2004). Progesterone attenuates corticotropin-releasing factor-enhanced but not fear-potentiated startle via the activity of its neuroactive metabolite, allopregnanolone. J Neurosci 24: 10280-10287.
59. Tringali G, Aubry J, Moscianese K, Zamori C, Vairano M, Preziosi P et al (2004). Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic neurotransmission. J Psychiatry Neurosci 29: 459-466.
60. Van den Buuse M, Eikelis N (2001). Estrogen increases prepulse inhibition of acoustic startle in rats. J Pharmacol 425: 33-41.
61. Van Nobelen M, Kokkinidis L (2006). Amygdaloid GABA, not glutamate neurotransmission or mRNA transcription controls footshock-associated fear arousal in the acoustic startle paradigm. Neuroscience 137: 707-716.
62. Woods NF, Lentz MJ, Mitchell ES, Heitkemper M, Shaver J, Henker R (1998). Perceived stress, physiological stress arousal, and premenstrual symptoms: group differences and intra-individual patterns. Res Nurs Health 21: 511-523.